Enzymes: Still cool after all these years
The first enzyme was discovered in 1833, almost 200 years ago and long before the nature of proteins was appreciated. The field of enzymology came into its own in the 20th century. Technological advances in the hands of creative enzymologists led to an ever-growing understanding of how enzymes achieve enormous rate accelerations as well as the structural basis for substrate specificity and allosteric regulation.
Submit an abstract
Abstract submission begins Sept. 14. If you submit by Oct. 12, you'll get a decision by Nov. 1. The regular submission deadline is Nov. 30.
Enzymologists continue to break new ground as we enter the 21st century. Our session at Discover BMB will feature new work on enzyme functions, mechanisms and applications.
Our first group of speakers will focus on enzymes that deal with problems caused by misbehaving metabolites. They will describe how enzymes can protect unstable intermediates and repair damaged metabolites. Our second group will explore the potential of using enzymes for biodegradation and green biosynthesis of chemicals currently produced from petrochemicals. Our final group will focus on enzymes that catalyze novel reactions, pushing the boundaries of chemistry accessible through biocatalysts.
Keywords: Substrate channeling, metabolite repair, biodegradation, green chemistry, natural product biosynthesis, radical chemistry.
Who should attend: Anyone who appreciates the awesome power of enzyme catalysis.
Theme song: by Paul Simon, because enzymes are crazy-efficient catalysts
This session is powered by the ribosome, which produces the enzymes that make life possible.
Cool and novel enzymes
Enzymatic control of problematic intermediates
Chair: Hung-Wen (Ben) Liu

Shelley D. Copley, University of Colorado Boulder
Tom Niehaus, University of Minnesota, Twin Cities
Shelley Minteer, University of Utah
Carole Linster, University of Luxembourg
Enzymes for a sustainable future
Chair: Shelley D. Copley
Gregg Beckham, National Renewable Energy Laboratory
Larry Wackett, University of Minnesota
Michelle Chang, University of California, Berkeley
Raquel Lieberman, Georgia Institute of Technology
New and unusual enzymatic transformations
Chair: Michelle Chang
Hung-wen (Ben) Liu, University of Texas at Austin
Aimin Liu, University of Texas at San Antonio
Sara O'Connor, Max Planck Institute for Chemical Ecology
Wenjun Zhang, University of California, Berkeley
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Understanding the roles of extracellular matrix and vesicles in valvular disease
MOSAIC scholar Cassandra Clift uses mass spectrometry and multiomics to study cardiovascular calcification and collagen dysregulation, bridging her background in bioengineering and biology to investigate extracellular vesicles and heart disease.

Lipid profiles reveal sex differences in type 2 diabetes
Researchers explored the lipid profiles of individuals with type 2 diabetes and identified potentially useful lipid biomarkers for this condition.

Serum lipids may predict early diabetes risk
Researchers found that levels of two key fatty acids may predict worsening tolerance for glucose, independent of body fat and insulin levels. In turn, these fatty acids may serve as early T2D biomarkers.

Sex and diet shape fat tissue lipid profiles in obesity
Researchers found that sex hormone levels and diet both influence inflammation and lipid composition in obesity.

Mapping the placenta鈥檚 hormone network
Study uncovers how the placenta actively metabolizes not only glucocorticoids but also novel androgens and progesterones, reshaping our understanding of pregnancy and its complications.

Biochemists and molecular biologists sweep major 2025 honors
Recent Nobel, MacArthur and Kimberly Prize honorees highlight the power of biochemistry and molecular biology to drive discovery, including immune tolerance, vaccine design and metabolic disease, and to advance medicine and improve human health.